How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
DNA Genetic Testing Market
- By Test Type: Ancestry Testing, Health Risk Testing, Carrier Screening, Pharmacogenomics Testing, Paternity Testing, Forensic Testing
- By Application: Personal Genomics, Clinical Diagnostics, Research and Development, Pharmaceutical Development, Agricultural Biotechnology
- By End User: Hospitals and Clinics, Diagnostic Laboratories, Direct-to-Consumer (DTC) Companies, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes
- By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray Analysis, Sanger Sequencing, Fluorescence In Situ Hybridization (FISH)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Ancestry Testing leads By Test Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.171 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the DNA Genetic Testing Market report
A complete, evidence-based study - 11 chapters and 119 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →AncestryDNA (Ancestry.com)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →23andMe Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →MyHeritage Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Invitae Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Fulgent Genetics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Gene by Gene Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Nebula Genomics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Color Genomics Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Veritas Genetics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BGI Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Pathway Genomics Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Living DNA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Circle DNA
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Helix OpCo Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →DNAfit
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Ancestry Testing32.8
- Health Risk Testing7.5
- Carrier Screening17.1
- Pharmacogenomics Testing15.1
- Paternity Testing13.6
- Forensic Testing13.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- AncestryDNA (Ancestry.com)14.3
- 23andMe Inc.16.7
- MyHeritage Ltd.5.1
- Invitae Corporation13.2
- Fulgent Genetics Inc.12.4
- Gene by Gene Ltd.10.4
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.5
- Europe21.1
- Asia Pacific22.0
- Latin America13.0
- Middle East and Africa9.3
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| AncestryDNA (Ancestry.com) | 87 | 76 | 96 | 76 | 83 | 97 | 86 |
| 23andMe Inc. | 77 | 71 | 72 | 88 | 93 | 81 | 80 |
| MyHeritage Ltd. | 79 | 70 | 85 | 76 | 77 | 88 | 79 |
| Invitae Corporation | 72 | 82 | 62 | 78 | 66 | 78 | 73 |
| Fulgent Genetics Inc. | 69 | 58 | 74 | 60 | 76 | 61 | 66 |
| Gene by Gene Ltd. | 64 | 54 | 64 | 63 | 57 | 47 | 58 |
| Nebula Genomics | 50 | 41 | 63 | 52 | 49 | 46 | 50 |
| Color Genomics Inc. | 52 | 41 | 55 | 36 | 46 | 35 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- AncestryDNA (Ancestry.com)
- 23andMe Inc.
- MyHeritage Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| AncestryDNA (Ancestry.com) | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| 23andMe Inc. | ✓ | ✓ | ◐ | ✓ | ✓ | ◐ |
| MyHeritage Ltd. | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Invitae Corporation | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Fulgent Genetics Inc. | ◐ | ◐ | ◐ | − | ◐ | ◐ |
| Gene by Gene Ltd. | ◐ | − | ◐ | − | ◐ | ◐ |
| Nebula Genomics | − | − | ◐ | − | − | − |
| Color Genomics Inc. | − | − | ◐ | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Challenger1
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Test Type in North America, then scale across DNA Genetic Testing Market — a $488M beachhead inside a $8.09B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Ancestry Testing
Best fit — highest urgency & budget in Test Type.
Health Risk Testing
Strong fit — clear ROI and a fast path to value.
Carrier Screening
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Test Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Test Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win DNA Genetic Testing Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
DNA Genetic Testing Market is a durable-growth opportunity — $2.06B by 2033, compounding at 9.1%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.1% CAGR
Demand compounds through 2033, outpacing GDP across Test Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Test Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
DNA Genetic Testing Market — a $7.83B market by 2033. Plan: grow share from 11.0% to 18.4%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.0% | 18.4% | Behind |
| Revenue | $868M | $1.44B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 35.2% | 43.6% | At risk |
| Customer retention | 92.0% | 95.2% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Test Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Test Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $215M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Test Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossBehind
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentBehind
Sales deck · value proposition
Win the DNA Genetic Testing Market conversation — a $12.5B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Test Type
Goal Grow share in Test Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your DNA Genetic Testing Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
DNA Genetic Testing Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →DNA Genetic Testing Kit Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportDNA Gel Stain Market
Market size, share, segmentation and regional forecast.
$797M market · 2025 base year
View reportDNA Fragment Synthesis Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportDNA Fragmentation Software Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportWater Soluble Vitamin Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportDNA Forensics Market
Market size, share, segmentation and regional forecast.
$386M market · 2025 base year
View reportDNA Extraction Reagent Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportDNA Extraction Equipment Market
Market size, share, segmentation and regional forecast.
$555M market · 2025 base year
View reportDNA Extraction and Analysis Equipment Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportDNA Encoded Compound Library Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportDNA-encoded Chemical Libraries (DEL) Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportDNA Dye Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy